In contrast, the pro‐inflammatory agonist serum amyloid A induces release of IL‐8 (CXCL8) and MMP3, and subsequent NF‐κB pathway activation, known to be important modulators of arthritis (Sodin‐Semrl et al., 2004). This evidence concerns the gene NFKB1 and arthritic joint disease.